JSR Life Sciences, LLC is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA. The two companies will occupy 8,700 square meters in Geneva’s ZIPLO (Industrial Zone Plan-les-Ouates) campus. KBI Biopharma’s expanded facility will enable the company to offer clinical cGMP biologics bulk drug substance manufacturing for European clients. Selexis’ new workspaces will...